Trappc11 is required for protein glycosylation in zebrafish and humans

Molecular Biology of the Cell

Volumn 27, Issue 8, 2016, Pages 1220-1234

  DeRossi, Charles ^a,b   Vacaru, Ana ^a,b   Rafiq, Ruhina ^a,b   Cinaroglu, Ayca ^a,b   Imriea, Dru ^a,c   Nayar, Shikha ^d   Baryshnikova, Anastasia ^e   Milev, Miroslav P ^f   Stanga, Daniela ^f   Kadakia, Dhara ^a   Gao, Ningguo ^g   Chu, Jaime ^d   Freeze, Hudson H ^h   Lehrman, Mark A ^g   Sacher, Michael ^f,i   Sadler, Kirsten C ^a,b,c  

^a Department of Medicine   (United States)

^b Department of Developmental and Regenerative Biology ^*  (United States)

^c Graduate School of Biomedical Sciences   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e PRINCETON UNIVERSITY   (United States)

^f Civil and Environmental Engineering   (Canada)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h BURNHAM INSTITUTE   (United States)

ⁱ MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; DOLICHOL; FAT DROPLET; LIPOOLIGOSACCHARIDE; MESSENGER RNA; PROTEIN; TERPENOID; TRANSPORT PROTEIN PARTICLE; TUBULIN; UNCLASSIFIED DRUG; LIPID; OLIGOSACCHARIDE; TERPENE; TRAPPC11 PROTEIN, HUMAN; TRAPPC11 PROTEIN, ZEBRAFISH; VESICULAR TRANSPORT PROTEIN; ZEBRAFISH PROTEIN;

ARTICLE; BIOSYNTHESIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FIBROBLAST; GENE; GENE EXPRESSION; GENE MUTATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; LIPID STORAGE; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; TRAPPC11 GENE; UPREGULATION; WESTERN BLOTTING; WILD TYPE; ZEBRA FISH; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETICS; GLYCOSYLATION; LARVA; METABOLISM; MUTATION; PATHOLOGY; SECRETION (PROCESS); TRANSGENIC ANIMAL; UNFOLDED PROTEIN RESPONSE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ATORVASTATIN CALCIUM; DOLICHOL; GLYCOSYLATION; GOLGI APPARATUS; HUMANS; LARVA; LIPIDS; LIVER; MUTATION; OLIGOSACCHARIDES; TERPENES; UNFOLDED PROTEIN RESPONSE; VESICULAR TRANSPORT PROTEINS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84963556413     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E15-08-0557     Document Type: Article

References (41)

1. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N (2004). Identifcation of 315 genes essential for early zebrafsh development. Proc Natl Acad Sci USA 101, 12792-12797.
2. Barrowman J, Bhandari D, Reinisch K, Ferro-Novick S (2010). TRAPP complexes in membrane traffc: convergence through a common Rab. Nat Rev Mol Cell Biol 11, 759-763.
3. Baryshnikova A (2015). Systematic functional annotation and visualization of biological networks. bioRxiv doi: 10.1101/030551.
4. Bassik MC, Kampmann M, Lebbink RJ, Wang S, Hein MY, Poser I, Wei-bezahn J, Horlbeck MA, Chen S, Mann M, et al. (2013). A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility. Cell 152, 909-922.
5. Behrends C, Sowa ME, Gygi S P, Harper JW (2010). Network organization of the human autophagy system. Nature 466, 68-76.
6. Bogershausen N, Shahrzad N, Chong JX, von Kleist-Retzow JC, Stanga D, Li Y, Bernier F P, Loucks CM, Wirth R, Puffenberger EG, et al. (2013). Recessive TRAPPC11 mutations cause a disease spectrum of limb girdle muscular dystrophy and myopathy with movement disorder and intellectual disability. Am J Hum Genet 93, 181-190.
7. Carss KJ, Stevens E, Foley AR, Cirak S, Riemersma M, Torelli S, Hoischen A, Willer T, van Scherpenzeel M, Moore SA, et al. (2013). Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of alpha-dystro-glycan. Am J Hum Genet 93, 29-41.
8. Chu J, Mir A, Gao N, Rosa S, Monson C, Sharma V, Steet R, Freeze HH, Lehrman MA, Sadler KC (2013). A zebrafsh model of congenital disorders of glycosylation with phosphomannose isomerase defciency reveals an early opportunity for corrective mannose supplementation. Dis Model Mech 6, 95-105.
9. Cinaroglu A, Gao C, Imrie D, Sadler KC (2011). Activating transcription factor 6 plays protective and pathological roles in steatosis due to endo-plasmic reticulum stress in zebrafsh. Hepatology 54, 495-508.
10. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, Sevier CS, Ding H, Koh JL, Toufghi K, Mostafavi S, et al. (2010). The genetic landscape of a cell. Science 327, 425-431.
11. Gao N, Lehrman MA (2002). Coupling of the dolichol-P-P-oligosaccharide pathway to translation by perturbation-sensitive regulation of the initiating enzyme, GlcNAc-1-P transferase. J Biol Chem 277, 39425-39435.
12. Gao N, Shang J, Huynh D, Manthati VL, Arias C, Harding H P, Kaufman RJ, Mohr I, Ron D, Falck JR, et al. (2011). Mannose-6-phosphate regulates destruction of lipid-linked oligosaccharides. Mol Biol Cell 22, 2994-3009.
13. Gao N, Shang J, Lehrman MA (2008). Unexpected basis for impaired Glc3Man9GlcNAc2-P-P-dolichol biosynthesis by elevated expression of GlcNAc-1-P transferase. Glycobiology 18, 125-134.
14. Gedeon AK, Colley A, Jamieson R, Thompson EM, Rogers J, Sillence D, Tiller GE, Mulley JC, Gecz J (1999). Identifcation of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda. Nat Genet 22, 400-404.
15. Gerhart SV, Eble DM, Burger RM, Oline SN, Vacaru A, Sadler KC, Jefferis R, Iovine MK (2012). The Cx43-like connexin protein Cx40.8 is differentially localized during fn ontogeny and fn regeneration. PLoS One 7, e31364.
16. Ghosh AK, Majumder M, Steele R, White RA, Ray RB (2001). A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1. Mol Cell Biol 21, 655-662.
17. Ghosh AK, Steele R, Ray RB (2003). Modulation of human luteinizing hormone beta gene transcription by MIP-2A. J Biol Chem 278, 24033-24038.
18. Howarth DL, Lindtner C, Vacaru AM, Sachidanandam R, Tsedensodnom O, Vasilkova T, Buettner C, Sadler KC (2014). Activating transcription factor 6 is necessary and suffcient for alcoholic fatty liver disease in zebrafsh. PLoS Genet 10, e1004335.
19. Howarth DL, Yin C, Yeh K, Sadler KC (2013). Defning hepatic dysfunction parameters in two models of fatty liver disease in zebrafsh larvae. Zebrafsh 10, 199-210.
20. Imrie D, Sadler KC (2012). Stress management: how the unfolded protein response impacts fatty liver disease. J Hepatol 57, 1147-1151.
21. Jacob V, Chernyavskaya Y, Chen X, Tan PS, Kent B, Hoshida Y, Sadler KC (2015). DNA hypomethylation induces a DNA replication-associated cell cycle arrest to block hepatic outgrowth in uhrf1 mutant zebrafsh embryos. Development 142, 510-521.
22. Jonikas MC, Collins SR, Denic V, Oh E, Quan EM, Schmid V, Weibezahn J, Schwappach B, Walter P, Weissman JS, et al. (2009). Comprehensive characterization of genes required for protein folding in the endoplas-mic reticulum. Science 323, 1693-1697.
23. Lehrman MA, Zhu XY, Khounlo S (1988). Amplifcation and molecular cloning of the hamster tunicamycin-sensitive N-acetylglucosamine-1-phosphate transferase gene. The hamster and yeast enzymes share a common peptide sequence. J Biol Chem 263, 19796-19803.
24. Liang W-C, Zhu W, Mitsuhashi S, Noguchi S, Sacher M, Ogawa M, Shi HH, Jong YH, Nishino I (2015). Congenital muscular dystrophy with fatty liver and infantile-onset cataract caused by TRAPPC11 mutations: broadening of the phenotype. Skelet Muscle 5, 29.
25. Lipatova Z, Hain AU, Nazarko VY, Segev N (2015). Ypt/Rab GTPases: principles learned from yeast. Crit Rev Biochem Mol Biol 50, 203-211.
26. Milev M P, Hasaj B, Saint-Dic D, Snounou S, Zhao Q, Sacher M (2015). TRAMM/TrappC12 plays a role in chromosome congression, kineto-chore stability, and CENP-E recruitment. J Cell Biol 209, 221-234.
27. Mir A, Kaufman L, Noor A, Motazacker MM, Jamil T, Azam M, Kahrizi K, Rafq MA, Weksberg R, Nasr T, et al. (2009). Identifcation of mutations in TRAPPC9, which encodes the NIK-and IKK-beta-binding protein, in nonsyndromic autosomal-recessive mental retardation. Am J Hum Genet 85, 909-915.
28. Oakes SA, Papa FR (2015). The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol 10, 173-194.
29. Parsons AB, Lopez A, Givoni IE, Williams DE, Gray CA, Porter J, Chua G, Sopko R, Brost RL, Ho CH, et al. (2006). Exploring the mode-of-action of bioactive compounds by chemical-genetic profling in yeast. Cell 126, 611-625.
30. Philippe O, Rio M, Carioux A, Plaza JM, Guigue P, Molinari F, Boddaert N, Bole-Feysot C, Nitschke P, Smahi A, et al. (2009). Combination of linkage mapping and microarray-expression analysis identifes NF-kappaB signaling defect as a cause of autosomal-recessive mental retardation. Am J Hum Genet 85, 903-908.
31. Rutkowski DT, Kaufman RJ (2007). That which does not kill me makes me stronger: adapting to chronic ER stress. Trends Biochem Sci 32, 469-476.
32. Rybak K, Steiner A, Synek L, Klaeger S, Kulich I, Facher E, Wanner G, Kuster B, Zarsky V, Persson S, et al. (2014). Plant cytokinesis is orchestrated by the sequential action of the TRAPPII and exocyst tethering complexes. Dev Cell 29, 607-620.
33. Sadler KC, Amsterdam A, Soroka C, Boyer J, Hopkins N (2005). A genetic screen in zebrafsh identifes the mutants vps18, nf2 and foie gras as models of liver disease. Development 132, 3561-3572.
34. Scrivens PJ, Noueihed B, Shahrzad N, Hul S, Brunet S, Sacher M (2011). C4orf41 and TTC-15 are mammalian TRAPP components with a role at an early stage in ER-to-Golgi traffcking. Mol Biol Cell 22, 2083-2093.
35. Tinkelenberg AH, Liu Y, Alcantara F, Khan S, Guo Z, Bard M, Sturley SL (2000). Mutations in yeast ARV1 alter intracellular sterol distribution and are complemented by human ARV1. J Biol Chem 275, 40667-40670.
36. Vacaru AM, Di Narzo AF, Howarth DL, Tsedensodnom O, Imrie D, Cinaroglu A, Amin S, Hao K, Sadler KC (2014a). Molecularly defned unfolded protein response subclasses have distinct correlations with fatty liver disease in zebrafsh. Dis Model Mech 7, 823-835.
37. Vacaru AM, Unlu G, Spitzner M, Mione M, Knapik EW, Sadler KC (2014b). In vivo cell biology in zebrafsh-providing insights into vertebrate development and disease. J Cell Sci 127, 485-495.
38. Wang S, Kaufman RJ (2014). How does protein misfolding in the endoplas-mic reticulum affect lipid metabolism in the liver? Curr Opin Lipidol 25, 125-132.
39. Wendler F, Gillingham AK, Sinka R, Rosa-Ferreira C, Gordon DE, Franch-Marro X, Peden AA, Vincent J P, Munro S (2010). A genome-wide RNA interference screen identifes two novel components of the metazoan secretory pathway. EMBO J 29, 304-314.
40. Wu J, Rutkowski DT, Dubois M, Swathirajan J, Saunders T, Wang J, Song B, Yau GD, Kaufman RJ (2007). ATF6alpha optimizes long-term endoplas-mic reticulum function to protect cells from chronic stress. Dev Cell 13, 351-364.
41. Xie J, Farage E, Sugimoto M, Anand-Apte B (2010). A novel transgenic zebrafsh model for blood-brain and blood-retinal barrier development. BMC Dev Biol 10, 76.